Dozens of peptide drugs have FDA approval, but BPC-157 is not among them. A look at why people are using it anyway.
Recap by typeshit. Post by Facebook on Facebook.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
The quip points at muscle loss during GLP-1 weight loss. Frigon says patients are told to add milk protein to help hold on to muscle.
Piotr Alvarez says HILIC flips elution order for semaglutide and tirzepatide, helping catch impurities, while TFA faces likely PFAS limits.
Loading…